To date, studies have shown that ERα36 is overexpressed in breast cancer stem cells18–21, ER-positive and -negative human breast carcinomas22, endometrial carcinomas23 and gastric carcinomas24, which is associated with malignancy, invasion, metastasis, drug resistance and poor prognosis of these tumors. Here, ESR1 is linked to breast cancer.